150 related articles for article (PubMed ID: 37302632)
21. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.
Farhadian A; Dounighi NM; Avadi M
Hum Vaccin Immunother; 2015; 11(12):2811-8. PubMed ID: 26158754
[TBL] [Abstract][Full Text] [Related]
22. Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon targeted delivery of 5-ASA pellets in rats with ulcerative colitis.
Shahdadi Sardou H; Akhgari A; Mohammadpour AH; Beheshti Namdar A; Kamali H; Jafarian AH; Afrasiabi Garekani H; Sadeghi F
Eur J Pharm Sci; 2022 Jan; 168():106072. PubMed ID: 34774715
[TBL] [Abstract][Full Text] [Related]
23. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
Xu M; Sun M; Qiao H; Ping Q; Elamin ES
Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
[TBL] [Abstract][Full Text] [Related]
24. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 5-ASA layered or matrix pellets coated with a combination of ethylcellulose and eudragits L and s in the treatment of ulcerative colitis in rats.
Sardou HS; Sadeghi F; Garekani HA; Akhgari A; Hossein Jafarian A; Abbaspour M; Nokhodchi A
Int J Pharm; 2023 Jun; 640():122981. PubMed ID: 37120124
[TBL] [Abstract][Full Text] [Related]
26. Novel Natural Carrier-Free Self-Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier.
Gao S; Zheng H; Xu S; Kong J; Gao F; Wang Z; Li Y; Dai Z; Jiang X; Ding X; Lei H
Adv Healthc Mater; 2023 Dec; 12(31):e2301826. PubMed ID: 37681364
[TBL] [Abstract][Full Text] [Related]
27. Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine.
Fukuda T; Naganuma M; Takabayashi K; Hagihara Y; Tanemoto S; Nomura E; Yoshimatsu Y; Sugimoto S; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Mutaguchi M; Inoue N; Ogata H; Iwao Y; Abe T; Kanai T
J Gastroenterol Hepatol; 2020 Nov; 35(11):1878-1885. PubMed ID: 32250471
[TBL] [Abstract][Full Text] [Related]
28. An oral pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis.
Yang M; Yang C; Zhang Y; Yan X; Ma Y; Zhang Y; Cao Y; Xu Q; Tu K; Zhang M
Biomater Sci; 2022 Feb; 10(4):1053-1067. PubMed ID: 35037010
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis.
Chen S; Chen Z; Wang Y; Hao W; Yuan Q; Zhou H; Gao C; Wang Y; Wu X; Wang S
J Adv Res; 2022 Sep; 40():263-276. PubMed ID: 36100331
[TBL] [Abstract][Full Text] [Related]
30. Development and
Singh A; Mandal UK; Narang RK
Assay Drug Dev Technol; 2022 Jan; 20(1):22-34. PubMed ID: 34780287
[TBL] [Abstract][Full Text] [Related]
31. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
32. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
33. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
[TBL] [Abstract][Full Text] [Related]
34. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
[TBL] [Abstract][Full Text] [Related]
35. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
[TBL] [Abstract][Full Text] [Related]
36. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
Int Immunopharmacol; 2015 Sep; 28(1):34-43. PubMed ID: 26002585
[TBL] [Abstract][Full Text] [Related]
37. 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
Tang H; Xiang D; Wang F; Mao J; Tan X; Wang Y
Mol Med Rep; 2017 Mar; 15(3):1117-1122. PubMed ID: 28138699
[TBL] [Abstract][Full Text] [Related]
38. Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota.
Wu C; Zheng T; Chen H; Zou P; Zhang M; Wang J; Li N; Zhang Y; Li Y; Dong Z
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144733
[TBL] [Abstract][Full Text] [Related]
39. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
Duan H; Lü S; Qin H; Gao C; Bai X; Wei Y; Wu X; Liu M; Zhang X; Liu Z
Int J Pharm; 2017 Jan; 516(1-2):214-224. PubMed ID: 27851980
[TBL] [Abstract][Full Text] [Related]
40. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
